Longitudinal changes of adiponectin, carbohydrate and lipid metabolism in pregnant women at high risk for gestational diabetes

Gynecological Endocrinology

Volumn 26, Issue 7, 2010, Pages 539-545

  Paradisi, Giancarlo ^a   Ianniello, Francesca ^a   Tomei, Claudia ^a   Bracaglia, Marina ^a   Carducci, Brigida ^a   Gualano, Maria Rosaria ^a   La Torre, Giuseppe ^b   Banci, Maria ^c   Caruso, Alessandro ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Valmontone Hospital   (Italy)

Author keywords

Adiponectin; Adiposity; Insulin resistance; Lipoproteins; Pregnancy

Indexed keywords

ADIPONECTIN; CARBOHYDRATE; GLUCOSE; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HIGH RISK PATIENT; HUMAN; INSULIN SENSITIVITY; LIPID METABOLISM; LONGITUDINAL STUDY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; RISK FACTOR; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BODY COMPOSITION; DIABETES, GESTATIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; PREGNANCY; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; RISK FACTORS;

EID: 77953635903     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513591003632084     Document Type: Article

References (32)

1. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003;148:293-300.
2. Hopkins TA, Ouchi N, Shibata R, Walsh K. Adiponectin actions in the cardiovascular system. Cardiovasc Res 2007;74: 11-18.
3. Matsuzawa Y. Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atherosclerosis (suppl) 2005;6:7-14.
4. Gorzelniak K, Angeli S, Jankr J, Luft FC, Sharma AM. Hormonal regulation of the human adipose-tissue reninangiotensin system: relationship to obesity and hypertension. J Hypertens 2002;20:965-973.
5. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, et al. Paradoxical decrease of an adipose specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
6. Stefan N, Stumvoll M. Adiponectin - its role in metabolism and beyond. Horm Metab Res 2002;4:469-474.
7. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, et al. Plasma concentration of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Artherioscler Thrombo Vasc Biol 2000;20:1595-1599.
8. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004;43:1318-1323.
9. Della Mea P, Lupia M, Bandolin V, Guzzon S, Sonino N, Vettor R, Fallo F. Adiponectin, insulin resistance and left ventricular structure in dipper and non-dipper essential hypertensive patients. Am J Hypertens 2005;18:30-35.
10. Mazaki-Tovi S, Kanety H, Sivan E. Adiponectin and human pregnancy. Curr Diab Rep 2005;5:278-281.
11. Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2004;89:2306-2311. (Pubitemid 38619868)
12. Worda C, Leipold H, Gruber C, Kautzky-Willer A, Knofler M, Bancher-Todesca D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 2004;191:2120-2124.
13. Kinalski M, Telejko B, Kuzmicki M, Kretowski A, Kinalska I. Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes. Horm Metab Res 2005;37:450-454.
14. Catalano PM, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S, Hauguel-De Mouzon S. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 2006;49:1677-1685.
15. Gao X, Yang H, Zhao Y. Variations of tumor necrosis factora, leptin and adiponectin in mid-trimester of gestational diabetes mellitus. Chin Med J 2008;121:701-705.
16. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31:S55-S60.
17. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-773.
18. Lukasky HC, Siders WA, Nielsen EJ. Total body water in pregnancy: assessment by using bioelectrical impedance. Am J Clin Nutr 1994;59:578-585.
19. Hosmer DW, Lemeshow S. Applied logistic regression, New York: Wiley; 1989.
20. Fuglsang J, Skjaerbaek C, Frystyk J, Flyvbjerg A, Ovesen P. A longitudinal study of serum adiponectin during normal pregnancy. Brit J Obstet Gynecol 2006;113:110-113.
21. Asai-Sato M, Okamoto M, Endo M, Yoshida H, Murase M, Ikeda M, Sakakibara H, Takahashi T, Hirahara F. Hypoadiponectinemia in lean lactating women: prolactin inhibits adiponectin secretion from human adipocytes. Endocrinol J 2006;53:555-562.
22. Lain KY, Daftary AR, Ness RB, Roberts JM. First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol (Oxf) 2008;69:407-411.
23. Ritterath C, Rad NT, Siegmund T, Heinze T, Siebert G, Buhling KJ. Adiponectin during pregnancy: correlation with fat metabolism, but not with carbohydrate metabolism. Arch Gynecol Obstet, 2009 Apr 19 [Epub ahead of print].
24. Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de Iasio R, Gentilcore E, Natale S, Cassader M, Rizzetto M, et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 2005;90: 3498-3504.
25. Ehrenberg HM, Huston-Presley L, Catalano PM. The influence of obesity and gestational diabetes mellitus on accretion and the distribution of adipose tissue in pregnancy. Am J Obstet Gynecol 2003;189:944-948.
26. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med 2004;21:103-113.
27. Bitó T, Nyári T, Kovács L, Pál A. Oral glucose tolerance testing at gestational weeks5or=16 could predict or exclude subsequent gestational diabetes mellitus during the current pregnancy in high risk group. Eur J Obstet Gynecol Reprod Biol 2005;121:51-55.
28. Björntorp P. The associations between obesity, adipose tissue distribution and disease. Acta Med Scand 1988;723: 121-134.
29. Abrams B, Parker J. Overweight and pregnancy complications. Int J Obes 1988;12:293-303.
30. Clark CM Jr, Qiu C, Amerman B, Porter B, Fineberg N, Aldasouqi S, Golichowski A. Gestational diabetes: should it be added to the syndrome of insulin resistance? Diabetes Care 1997;20:867-871.
31. Toescu V, Nuttall SL, Martin U, Nightingale P, Kendall MJ, Brydon P, Dunne F. Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. Clin Sci 2004;106:93-98.
32. Sattar N, Wannamethee SG, Forouhi NG. Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? Diabetologia 2008;51:926-940.